ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,140.16
-0.52%
Dow Jones
40,211.72
0.00%
Gold vs US Dollar
2,434.645
0.51%
Brent Oil
82.85
-1.77%
Bitcoin
63,806.50
-1.61%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)

  7. Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) News

ENZYMOTEC LTD. (ENZY)

Enzymotec Ltd. - Ordinary Shares (delisted)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ENZY
DateTimeSourceHeadlineSymbolCompany
17/05/201712:59Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
17/05/201712:30GlobeNewswire Inc.Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/05/201713:25Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/05/201713:30GlobeNewswire Inc.Enzymotec to Report First Quarter 2017 Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
02/05/201713:30GlobeNewswire Inc.VAYA Pharma Introduces New Three-Month Supply of Vayarin® and Vayacog® Medical FoodsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
26/04/201713:47Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/04/201715:37GlobeNewswireEnzymatica AB: Bulletin from annual general meeting 2017 in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
20/04/201707:30GlobeNewswireEnzymatica AB: Breakthrough in Germany and continued increase in salesNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
06/04/201720:33GlobeNewswireEnzymatica AB: Enzymatica - publication of the annual report 2016NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
05/04/201710:35GlobeNewswireEnzymatica AB: Completing the Nomination Committee's in Enzymatica AB proposal for AGM 2017 regarding election of auditorNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/04/201713:26Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
03/04/201713:15GlobeNewswire Inc.Neptune and Enzymotec Reach Patent Agreement Ending All LitigationNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
21/03/201715:02GlobeNewswireEnzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/03/201720:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/03/201715:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/03/201712:30GlobeNewswire Inc.Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/03/201711:48Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/03/201713:41Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
10/03/201713:30GlobeNewswire Inc.Enzymotec Ltd. Calls an Extraordinary General Meeting of ShareholdersNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
09/03/201713:41Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
09/03/201713:30GlobeNewswire Inc.Enzymotec Ltd. Announces the Appointment of Erez Israeli as President and CEONASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
02/03/201711:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
22/02/201712:30GlobeNewswire Inc.Enzymotec Ltd. Reports Fourth Quarter and Full Year 2016 Unaudited Financial ResultsNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
16/02/201707:30GlobeNewswireEnzymatica AB: Geographic expansion and continued growth in 2016NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
15/02/201712:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
14/02/201722:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
13/02/201711:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
13/02/201707:30GlobeNewswireEnzymatica AB: Enzymatica enters into partnership agreement with STADA Arzneimittel AGNASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
08/02/201720:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
06/02/201714:19Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENZYEnzymotec Ltd. - Ordinary Shares (delisted)
 Showing the most relevant articles for your search:NASDAQ:ENZY

Your Recent History

LSE
UB01
Ubsetf E50gba
NYSE
PBA
Pembina Pipeline
NASDAQ
AGNC
AGNC Investment
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved